▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Exagen (NASDAQ: XGN)

$10.96

(-0.3%)

-$0.03

Price as of October 1, 2025, 1:20 p.m. ET

Exagen Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
XGN	+255.66%	-2.31%	-0.47%	-41%
S&P	+16.07%	+97.84%	+14.62%	+122%

Exagen Company Info

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

News & Analysis

Featured Article

Exagen Q2 Revenue Jumps 14 Percent

Motley Fool Markets Team | Jul 29, 2025

Valuation

Earnings Transcripts

Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript

XGN earnings call for the period ending June 30, 2022.

Motley Fool Transcribing | Aug 5, 2022

Exagen Inc. (XGN) Q1 2022 Earnings Call Transcript

XGN earnings call for the period ending March 31, 2022.

Motley Fool Transcribing | May 11, 2022

Exagen Inc. (XGN) Q4 2021 Earnings Call Transcript

XGN earnings call for the period ending December 31, 2021.

Motley Fool Transcribing | Mar 22, 2022

Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript

XGN earnings call for the period ending September 30, 2021.

Motley Fool Transcribing | Nov 11, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services